| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ... New England journal of medicine 371 (11), 1005-1015, 2014 | 1566 | 2014 |
| JAK mutations in high-risk childhood acute lymphoblastic leukemia CG Mullighan, J Zhang, RC Harvey, JR Collins-Underwood, ... Proceedings of the National Academy of Sciences 106 (23), 9414-9418, 2009 | 759 | 2009 |
| Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells S Gill, SK Tasian, M Ruella, O Shestova, Y Li, DL Porter, M Carroll, ... Blood, The Journal of the American Society of Hematology 123 (15), 2343-2354, 2014 | 542 | 2014 |
| Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia SL Maude, SK Tasian, T Vincent, JW Hall, C Sheen, KG Roberts, AE Seif, ... Blood, The Journal of the American Society of Hematology 120 (17), 3510-3518, 2012 | 366 | 2012 |
| Philadelphia chromosome–like acute lymphoblastic leukemia SK Tasian, ML Loh, SP Hunger Blood, The Journal of the American Society of Hematology 130 (19), 2064-2072, 2017 | 317 | 2017 |
| Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study IM Chen, RC Harvey, CG Mullighan, J Gastier-Foster, W Wharton, H Kang, ... Blood, The Journal of the American Society of Hematology 119 (15), 3512-3522, 2012 | 309 | 2012 |
| Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia SK Tasian, MY Doral, MJ Borowitz, BL Wood, IM Chen, RC Harvey, ... Blood, The Journal of the American Society of Hematology 120 (4), 833-842, 2012 | 277 | 2012 |
| Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia SL Maude, S Dolai, C Delgado-Martin, T Vincent, A Robbins, ... Blood, The Journal of the American Society of Hematology 125 (11), 1759-1767, 2015 | 262 | 2015 |
| Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia J Vadakekolathu, MD Minden, T Hood, SE Church, S Reeder, H Altmann, ... Science translational medicine 12 (546), eaaz0463, 2020 | 184 | 2020 |
| Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia SK Tasian, SS Kenderian, F Shen, M Ruella, O Shestova, M Kozlowski, ... Blood, The Journal of the American Society of Hematology 129 (17), 2395-2407, 2017 | 181 | 2017 |
| Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia SK Tasian, DT Teachey, Y Li, F Shen, RC Harvey, IM Chen, T Ryan, ... Blood, The Journal of the American Society of Hematology 129 (2), 177-187, 2017 | 178 | 2017 |
| A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 … ML Loh, SK Tasian, KR Rabin, P Brown, D Magoon, JM Reid, X Chen, ... Pediatric blood & cancer 62 (10), 1717-1724, 2015 | 141 | 2015 |
| Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein H Qin, M Cho, W Haso, L Zhang, SK Tasian, HZ Oo, GL Negri, Y Lin, ... Blood, The Journal of the American Society of Hematology 126 (5), 629-639, 2015 | 137 | 2015 |
| CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL) SK Tasian, RA Gardner Therapeutic advances in hematology 6 (5), 228-241, 2015 | 128 | 2015 |
| Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia S Gandre-Babbe, P Paluru, C Aribeana, ST Chou, S Bresolin, L Lu, ... Blood, The Journal of the American Society of Hematology 121 (24), 4925-4929, 2013 | 128 | 2013 |
| Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies SK Tasian, DT Teachey, SR Rheingold Frontiers in oncology 4, 108, 2014 | 127 | 2014 |
| Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia RC Harvey, SK Tasian Blood advances 4 (1), 218-228, 2020 | 115 | 2020 |
| Clinical utility of custom-designed NGS panel testing in pediatric tumors LF Surrey, SP MacFarland, F Chang, K Cao, KS Rathi, GT Akgumus, ... Genome medicine 11, 1-14, 2019 | 111 | 2019 |
| Childhood acute lymphoblastic leukemia: Integrating genomics into therapy SK Tasian, ML Loh, SP Hunger Cancer 121 (20), 3577-3590, 2015 | 111 | 2015 |
| Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics SK Tasian, SP Hunger British journal of haematology 176 (6), 867-882, 2017 | 110 | 2017 |
Mignon LohProfessor of Pediatrics, UCSFDirección de correo verificada de ucsf.edu
